ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

Katja Kaipio; Ping Chen; Pia Roering; Kaisa Huhtinen; Piia Mikkonen; Päivi Östling; Laura Lehtinen; Naziha Mansuri; Taina Korpela; Swapnil Potdar; Johanna Hynninen; Annika Auranen; Seija Grénman; Krister Wennerberg; Sampsa Hautaniemi; Olli Carpén

doi:10.1002/path.5356

ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

Katja Kaipio
, Ping Chen
, Pia Roering
, Kaisa Huhtinen
, Piia Mikkonen
, Päivi Östling
, Laura Lehtinen
, Naziha Mansuri
, Taina Korpela
, Swapnil Potdar
, Johanna Hynninen
, Annika Auranen
, Seija Grénman
, Krister Wennerberg
, Sampsa Hautaniemi
, Olli Carpén

Wennerberg Group

Research output: Contribution to journal › Journal article › Research › peer-review

112 Downloads (Pure)

Original language	English
Journal	Journal of Pathology
Volume	250
Issue number	2
Pages (from-to)	159-169
Number of pages	10
ISSN	0022-3417
DOIs	https://doi.org/10.1002/path.5356
Publication status	Published - 2020

Access to Document

10.1002/path.5356

Kaipio_et_al_2019_The_Journal_of_PathologyAccepted author manuscript, 2.2 MB

Library access?

Check availability at the Royal Danish Library

Cite this

Kaipio, K., Chen, P., Roering, P., Huhtinen, K., Mikkonen, P., Östling, P., Lehtinen, L., Mansuri, N., Korpela, T., Potdar, S., Hynninen, J., Auranen, A., Grénman, S., Wennerberg, K., Hautaniemi, S., & Carpén, O. (2020). ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors. Journal of Pathology, 250(2), 159-169. https://doi.org/10.1002/path.5356

ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors. / Kaipio, Katja; Chen, Ping; Roering, Pia et al.
In: Journal of Pathology, Vol. 250, No. 2, 2020, p. 159-169.

Research output: Contribution to journal › Journal article › Research › peer-review

Kaipio, K, Chen, P, Roering, P, Huhtinen, K, Mikkonen, P, Östling, P, Lehtinen, L, Mansuri, N, Korpela, T, Potdar, S, Hynninen, J, Auranen, A, Grénman, S, Wennerberg, K, Hautaniemi, S & Carpén, O 2020, 'ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors', Journal of Pathology, vol. 250, no. 2, pp. 159-169. https://doi.org/10.1002/path.5356

@article{6f0b8b3b1e8d4f81a15bd6964e0004c1,

title = "ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors",

author = "Katja Kaipio and Ping Chen and Pia Roering and Kaisa Huhtinen and Piia Mikkonen and P{\"a}ivi {\"O}stling and Laura Lehtinen and Naziha Mansuri and Taina Korpela and Swapnil Potdar and Johanna Hynninen and Annika Auranen and Seija Gr{\'e}nman and Krister Wennerberg and Sampsa Hautaniemi and Olli Carp{\'e}n",

year = "2020",

doi = "10.1002/path.5356",

language = "English",

volume = "250",

pages = "159--169",

journal = "Journal of Pathology",

issn = "0022-3417",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

AU - Kaipio, Katja

AU - Chen, Ping

AU - Roering, Pia

AU - Huhtinen, Kaisa

AU - Mikkonen, Piia

AU - Östling, Päivi

AU - Lehtinen, Laura

AU - Mansuri, Naziha

AU - Korpela, Taina

AU - Potdar, Swapnil

AU - Hynninen, Johanna

AU - Auranen, Annika

AU - Grénman, Seija

AU - Wennerberg, Krister

AU - Hautaniemi, Sampsa

AU - Carpén, Olli

PY - 2020

Y1 - 2020

U2 - 10.1002/path.5356

DO - 10.1002/path.5356

M3 - Journal article

C2 - 31595974

SN - 0022-3417

VL - 250

SP - 159

EP - 169

JO - Journal of Pathology

JF - Journal of Pathology

IS - 2

ER -